Impax Laboratories Inc. (IPXL) reported fourth quarter adjusted EPS of $0.62 Monday morning, up from $0.16 a year ago. Analysts expected EPS of $0.44. Full year 2016 adjusted EPS is expected to increase at least 10% over the full year 2015 adjusted diluted EPS of $1.45. The consensus estimate is for EPS of $2.28.
from RTT - Momentum http://ift.tt/1Q5A915
via IFTTT
No comments:
Post a Comment